Bulmer, Andrew C. and Blanchfield, Joanne T. and Toth, Istvan and Fassett, Robert G. and Coombes, Jeff S. (2008) Improved resistance to serum oxidation in Gilbert's Syndrome: a mechanism for cardiovascular protection. Atherosclerosis, 199 . pp. 390-396. ISSN 0021-9150
|HTML Citation||EndNote||Dublin Core||Reference Manager|
Full text not available from this archive.
Official URL: htp://dx.doi.org/10.1016j.atherosclerosis.2007.11.022
Identification Number or DOI: doi: 10.1016j.atherosclerosis.2007.11.022
Bilirubin is a potent antioxidant, however, uncertainty surrounds its physiological importance. Individuals with Gilbert’s syndrome (GS)have increased circulating bilirubin and a reduced prevalence of cardiovascular disease (CVD). The aim of this study was to investigate mechanisms that may link bilirubin to protection from CVD seen in GS by examining markers of antioxidant and oxidative stress status and the susceptibility of serum to oxidation. Nine individuals with GS and twelve controls, matched for age, height and weight, were assessed for plasma antioxidant status, red blood cell antioxidant enzyme activities, plasma malondialdehyde, the susceptibility of serum to copper (Cu2+) induced oxidation and blood lipid profile. Individuals with GS had significantly elevated unconjugated bilirubin (GS: 26.0±6.4; control: 9.7±3.0!mol/L; P < 0.001), increased trolox equivalent antioxidant capacity (GS: 1.59±0.07; control: 1.52±0.07 mmol/L trolox Equ; P = 0.035) and ferric reducing ability of plasma (GS: 1.09±0.16; control: 0.92±0.14 mmol/L Fe2+ Equ; P = 0.024). The lag phase of serum oxidation was significantly longer in the GS group (GS: 121.4±10.5; control: 106.8±14.6 min; P = 0.020) and was positively correlated with the bilirubin concentration (r = 0.451, P = 0.040). A trend toward elevated HDL:LDL ratio was observed in GS (GS 0.96±0.31; control: 0.73±0.21; P = 0.072). In summary, individuals with GS have an increased circulating antioxidant status and an improved resistance to serum oxidation which may partially explain their reduced prevalence of CVD.
|Item Type:||Article (Commonwealth Reporting Category C)|
|Additional Information:||Author version not held.|
|Uncontrolled Keywords:||Cardiovascular disease; Bilirubin; Superoxide; Glutathione; catalase; Trolox equivalent antioxidant capacity; ferric reducing ability of plasma; high and low density lipoprotein cholesterol|
|Fields of Research (FOR2008):||11 Medical and Health Sciences > 1102 Cardiovascular Medicine and Haematology > 110299 Cardiovascular Medicine and Haematology not elsewhere classified|
|Socio-Economic Objective (SEO2008):||E Expanding Knowledge > 97 Expanding Knowledge > 970111 Expanding Knowledge in the Medical and Health Sciences|
|Deposited On:||05 May 2010 22:41|
|Last Modified:||16 Nov 2011 14:37|
Archive Staff Only: edit this record